Identification,control strategies,and analytical approaches for the determination of potential genotoxic impurities in pharmaceuticals: A comprehensive review

Potential genotoxic impurities in pharmaceuticals at trace levels are of increasing concern to both pharmaceutical industries and regulatory agencies due to their possibility for human carcinogenesis. Molecular functional groups that render starting materials and synthetic intermediates as reactive building blocks for small molecules may also be responsible for their genotoxicity. Determination of these genotoxic impurities at trace levels requires highly sensitive and selective analytical methodologies, which poses tremendous challenges on analytical communities in pharmaceutical research and development. Experimental guidance for the analytical determination of some important classes of genotoxic impurities is still unavailable in the literature. Therefore, the present review explores the structural alerts of commonly encountered potential genotoxic impurities, draft guidance of various regulatory authorities in order to control the level of impurities in drug substances and to assess their toxicity. This review also describes the analytical considerations for the determination of potential genotoxic impurities at trace levels and finally few case studies are also discussed for the determination of some important classes of potential genotoxic impurities. It is the authors’ intention to provide a complete strategy that helps analytical scientists for the analysis of such potential genotoxic impurities in pharmaceuticals.     

Synthesis of a Novel Chitosan/Basil Oil Blend and Development of Novel Low Density Poly Ethylene/Chitosan/Basil Oil Active Packaging Films Following a Melt-Extrusion Process for Enhancing Chicken Breast Fillets Shelf-Life

An innovative process for the adsorption of the hydrophobic Basil-Oil (BO) into the hydrophilic food byproduct chitosan (CS) and the development of an advanced low-density polyethylene/chitosan/basil-oil (LDPE/CS_BO) active packaging film was investigated in this work. The idea of this study was the use of the BO as both a bioactive agent and a compatibilizer. The CS was modified to a CS_BO hydrophobic blend via a green evaporation/adsorption process. This blend was incorporated directly in the LDPE to produce films with advanced properties. All the obtained composite films exhibited improved packaging properties. The film with 10% CS_BO content exhibited the best packaging properties, i.e., 33.0% higher tensile stress, 31.0% higher water barrier, 54.3% higher oxygen barrier, and 12.3% higher antioxidant activity values compared to the corresponding values of the LDPE films. The lipid oxidation values of chicken breast fillets which were packaged under vacuum using this film were measured after seven and after fourteen days of storage. These values were found to be lower by around 41% and 45%, respectively, compared with the corresponding lipid oxidation values of pure LDPE film.     

Ag and Cu loaded on TiO<Subscript>2</Subscript>/graphite as a catalyst for <Emphasis Type="Italic">Escherichia coli</Emphasis>-contaminated water disinfection

TiO₂ film was synthesized by means of the chemical bath deposition (CBD) method from TiCl₄ as a precursor and surfactant cetyl trimethyl ammonium bromide (CTAB) as a linking and assembling agent of the titanium hydroxide network on a graphite substrate. Ag and Cu were loaded on the TiO₂ film by means of electrodeposition at various applied currents. Photoelectrochemical testing on the composite of Ag-TiO₂/G and Cu-TiO₂/G was used to define the composite for Escherichia coli-contaminated water disinfection. Disinfection efficiency and the rate of disinfection of E. coli-contaminated water with Ag-TiO₂/G as a catalyst was higher than that observed for Cu-TiO₂/G in all disinfection methods including photocatalysis (PC), electrocatalysis (EC), and photoelectrocatalysis (PEC). The highest rate constant was achieved by the PEC method using Ag-TiO₂/G, k was 6.49 × 10⁻² CFU mL⁻¹ min⁻¹. Effective disinfection times of 24 h (EDT₂₄) and 48 h (EDT₄₈) were achieved in all methods except the EC method using Cu-TiO₂/G.     

In search for mixed transition metal/lanthanide single-molecule magnets: Synthetic routes to NiII/TbIII and NiII/DyIII clusters featuring a 2-pyridyl oximate ligand

Employing the mononuclear complex [Ni{(py)C(Me)NO}₂{(py)C(Me)NOH}] (1) as ‘ligand’ [(py)C(Me)NOH = methyl 2-pyridyl ketone oxime], the use of the ‘metal complexes as ligands’ approach has led to the synthesis of the mixed Ni^II/Ln^III complexes [NiTb{(py)C(Me)NO}₂(NO₃)₃{(py)C(Me)NOH}] (2), [Ni₂Ln₂{(py)C(Me)NO}₆(NO₃)₄] (Ln = Dy, 3; Ln = Tb, 4) and [Ni₂Tb{(py)C(Me)NO}₆](NO₃) (5). The structures of 2, 3, and 5, and the magnetic properties of 2 and 5 are briefly discussed.     

The problem of Dirichlet for anisotropic quasilinear degenerate elliptic equations

We consider the Dirichlet problem for a class of anisotropic degenerate elliptic equations. New a priori estimates for solutions and for the gradient of solutions are established. Based on these estimates sufficient conditions guaranteeing the solvability of the problem are formulated. The results are new even in the semilinear case when the principal part is the Laplace operator.     

Carbon magnetic resonance spectra of representative organometallic π-propene complexes

The ¹⁹C magnetic resonance spectra of silver, rhodium and iron complexes of propene are reported and discussed.     

Preparation,structural characterization,and acid-catalyzed isomerization of 3-, 7-, and 9-benzyl-6-benzylthiopurines

Benzylation of 6-benzylthiopurine was examined. Structural assignments of the products were determined by 1-D and 2-D nmr spectroscopy (HMQC, HMBC, and nOe). In the presence of base, the isomeric N3-, N7-, and N9-benzylated products 4, 3 , and 2 were isolated; however, only 9-benzyl-6-benzylthio-purine ( 2 ) was obtained in the absence of base. In the latter case, the initially formed N3- and N7-isomers were, in the presence of acid, converted to 9-benzyl-6-benzylthiopurine ( 2 ) via a 6-benzylthiopurine intermediate as evidenced by analysis of the reaction over time using reversed-phase hplc.